Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q1 2026 · 10-Q
Revenue—
Net Income-$2.20M-$2.20MN/M vs Q1 2025 EPS Diluted-$0.51-$0.51N/M vs Q1 2025 Operating Income-$2,255,927N/M Operating Cash Flow-$2,200,644N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 8, 2026 · 38 d after period end